NeuroDerm Ltd. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.
The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.
“Previous animal studies found that ND0611 modified levodopa pharmacokinetics by (i) increasing levodopa plasma half-life and area-under-thecurve (AUC), (ii) maintaining levodopa plasma concentrations in a typical therapeutic range, and (iii) extending dopaminergic stimulation in the brain.” Read the following article
NeuroDerm Ltd. is a clinical-stage pharmaceutical company, which engages in the development of next-generation treatments for the central nervous system. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. [Source: MarketWatch]
Company Website: http://neuroderm.com